Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
King's invasive aspergillosis study II
ISRCTN11847553Phase 4Completed
- Sponsor
- King's College Hospital
- Start
- Jan 2017
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive mycoses and invasive aspergillosis (IA), sponsored by King's College Hospital. Primary endpoint: Cumulative incidence of invasive fungal disease. Started Jan 2017; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive mycosesinvasive aspergillosis (IA)
Beyond the preview
Go deeper on ISRCTN11847553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11847553.